Desvenlafaxine Succinate
Product Images NDC 50090-4069

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine Succinate (NDC 50090-4069). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Desvenlafaxine 01)

FDA Label Image

Figure 1 (Desvenlafaxine 02)

Figure 1 (Desvenlafaxine 02)
This is a table displaying the effect of renal and hepatic impairment, gender, and age on drug absorption (Cmax) and exposure (AUC) as well as geometric mean ratios. The drug seems to be named PK. The table also contains a note explaining ESRD stands for End-Stage Renal Disease.*
FDA Label Image

Figure 2 (Desvenlafaxine 03)

Figure 2 (Desvenlafaxine 03)
This text shows the geometric mean ratios (with 90% confidence intervals) for Cmax and AUC of ketoconazole, which is a CYP3A4 inhibitor. The table also displays the changes relative to the reference values for different time intervals.*
FDA Label Image

Figure 3 (Desvenlafaxine 04)

FDA Label Image

Figure 4 (Desvenlafaxine 05)

Figure 4 (Desvenlafaxine 05)
This is a graph that shows the estimated proportion of patients with relapse over time after being randomized to either Desvenlafaxine 50mg or a placebo. The graph shows that after approximately 200 days from randomization, the proportion of patients with relapse was around 40-50%.*
FDA Label Image

Figure 5 (Desvenlafaxine 06)

Figure 5 (Desvenlafaxine 06)
The given text represents a graph that shows the estimated proportion of patients with relapse over time (in days from randomization). The graph compares patients treated with desvenlafaxine versus placebo, with the x-axis representing time and the y-axis representing the percentage of patients with relapse.*
FDA Label Image

Logo (Desvenlafaxine 07)

Logo (Desvenlafaxine 07)
This is a description of a brand called "Greenstone", distributed by Greenstone LLC with headquarters located in Peapack, NJ 07977.*
FDA Label Image

Logo (Desvenlafaxine 08)

Logo (Desvenlafaxine 08)
This text indicates that there is a brand called "Greenstone®" that is distributed by a company called "Greenstone LLC" located in Peapack, NJ 07977.*
FDA Label Image

Label Image (Lbl500904069)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.